Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Division of Dermatology, Vanderbilt School of Medicine, Nashville, Tenn. 37232.
Systemic corticosteroids may be either contraindicated or not efficacious in treating the cutaneous manifestations occurring in 20% to 35% of patients with systemic sarcoidosis. Chloroquine phosphate has been reported to be a valuable alternative therapy for cutaneous lesions of sarcoidosis. With a judiciously determined daily dosage and regular 6-month ophthalmologic follow-up examinations, the risk of developing retinopathy can be avoided, because the daily dosage rate rather than total dose accumulation determines the development of chloroquine-induced retinopathy. We reviewed the efficacy and safety of chloroquine and its role in the treatment of cutaneous sarcoidosis.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on